Showing results (441-450 of 722) with videos related to
Sort By:
Pageof 73
The Lancet. Haematology|August 16, 2017
Measurement of peripheral venous catheter-related phlebitis: a cross-sectional studyKatarina Göransson, Ulrika Förberg, Eva Johansson, et al.The Lancet. Haematology|August 23, 2017
Updated analysis of CALGB (Alliance) 100104 assessing lenalidomide versus placebo maintenance after single autologous stem-cell transplantation for multiple myeloma: a randomised, double-blind, phase 3 trialSarah A Holstein, Sin-Ho Jung, Paul G Richardson, et al.The Lancet. Haematology|November 3, 2019
International prognostic scoring system for mastocytosis (IPSM): a retrospective cohort studyWolfgang R Sperr, Michael Kundi, Ivan Alvarez-Twose, et al.The Lancet. Haematology|December 18, 2017
Imaging of subclinical haemopoiesis after stem-cell transplantation in patients with haematological malignancies: a prospective pilot studyKirsten M Williams, Jennifer Holter-Chakrabarty, Liza Lindenberg, et al.The Lancet. Haematology|May 16, 2022
Addition of navitoclax to ongoing ruxolitinib treatment in patients with myelofibrosis (REFINE): a post-hoc analysis of molecular biomarkers in a phase 2 studyNaveen Pemmaraju, Jacqueline S Garcia, Jalaja Potluri, et al.The Lancet. Haematology|July 5, 2021
Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort studyKazimieras Maneikis, Karolis Šablauskas, Ugnė Ringelevičiūtė, et al.The Lancet. Haematology|June 25, 2021
CPX-351 versus 7+3 cytarabine and daunorubicin chemotherapy in older adults with newly diagnosed high-risk or secondary acute myeloid leukaemia: 5-year results of a randomised, open-label, multicentre, phase 3 trialJeffrey E Lancet, Geoffrey L Uy, Laura F Newell, et al.The Lancet. Haematology|June 25, 2021
Iron preparations for women of reproductive age with iron deficiency anaemia in pregnancy (FRIDA): a systematic review and network meta-analysisEwelina Rogozińska, Jahnavi Daru, Marios Nicolaides, et al.The Lancet. Haematology|February 1, 2020
Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow TransplantationOlaf Penack, Monia Marchetti, Tapani Ruutu, et al.The Lancet. Haematology|February 1, 2020
Tumour lysis syndrome in patients with chronic lymphocytic leukaemia treated with BCL-2 inhibitors: risk factors, prophylaxis, and treatment recommendationsFrancesco Paolo Tambaro, William G WierdaPageof 73